Clinical Trials Directory

Trials / Unknown

UnknownNCT06381245

First-time Ablation of Atrial Fibrillation Registry

Status
Unknown
Phase
Study type
Observational
Enrollment
400 (estimated)
Sponsor
Medical University of Warsaw · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers

Summary

Atrial fibrillation (AF) is a prevalent cardiac arrhythmia affecting millions globally, with projections indicating a doubling of cases by 2050. AF is linked to heightened cardiovascular risks like stroke and increased healthcare costs. Ablation, targeting the arrhythmia substrate, is a method to manage AF, yet recurrence rates remain high (20-45% in the first year). Studies highlight the impact of comorbidities, AF characteristics, ablation techniques, and myocardial remodeling markers on AF progression and ablation efficacy. However, there's no definitive guidance on selecting these factors for predicting treatment success. The aim of this study is to investigate predictors of successful AF ablation in the following areas: (a) clinical factors, (b) electrophysiological, (c) electrocardiographic, (d) ultrasound, (e) cardiac anatomy, (f) biomarkers.

Detailed description

AF is a multifactorial disease influenced by many possible mechanisms. This study will examine several different predictors of successful AF ablation: (a) clinical factors, (b) electrophysiological, (c) electrocardiographic, (d) ultrasound, (e) cardiac anatomy, (f) biomarkers. Analysis of these factors will help determine the optimal combination of predictors of successful ablation. This combination of prognostic factors can then be used to tailor therapeutic decisions specifically to individual patients and to improve patient selection for invasive treatment. Better patient selection and choice of ablation type can help increase success rates and avoid unnecessary procedures and their associated risks.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTPPG-based remote heart rhythm/rate monitoringPPG-based remote heart rhythm/rate monitoring
DIAGNOSTIC_TESTECG-based remote heart rhythm/rate monitoringECG-based remote heart rhythm/rate monitoring
DIAGNOSTIC_TESTTransthoracic and transesophageal echocardiography examinationTransthoracic and transesophageal echocardiography examination
DIAGNOSTIC_TESTLiver ultrasound examinationLiver ultrasound examination
DIAGNOSTIC_TESTRotational angiography with three-dimensional reconstructionRotational angiography with three-dimensional reconstruction
DIAGNOSTIC_TESTBlood-derived biomarker analysisBlood-derived biomarker analysis
DIAGNOSTIC_TESTMobile health-based spirometryMobile health-based spirometry

Timeline

Start date
2023-12-01
Primary completion
2026-03-31
Completion
2026-03-31
First posted
2024-04-24
Last updated
2024-08-13

Locations

1 site across 1 country: Poland

Source: ClinicalTrials.gov record NCT06381245. Inclusion in this directory is not an endorsement.